![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
-Induced Cell Death by Suppression of Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation and Activation of Akt/Cyclic AMP Response Element-Binding Protein Phosphorylation
Department of Pharmacology (K.W.H., K.Y.K., H.K.S., J.H.L., J.M.C., C.D.K., W.S.L., B.Y.R.), College of Medicine and Research Institute of Genetic Engineering (K.W.H.), Pusan National University, Busan, Korea; and Institute of Cardiovascular Research (Y.-G.K.), Chonbuk National University, Chonbuk, Korea
This study examines the signaling mechanism by which cilostazol prevents
neuronal cell death. Cilostazol (
0.1-100 µM) prevented tumor necrosis
factor-
(TNF-
)-induced decrease in viability of SK-N-SH and
HCN-1A cells, which was antagonized by 1 µM iberiotoxin, a maxi-K channel
blocker. TNF-
did not suppress the viability of the U87-MG cell, a
phosphatase and tensin homolog deleted from chromosome 10 (PTEN)-null
glioblastoma cell, but it did decrease viability of U87-MG cells transfected
with expression vectors for the sense PTEN, and this decrease was also
prevented by cilostazol. Cilostazol as well as
1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one
(NS-1619) and
(3S)(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indole-2-one
(BMS 204352), maxi-K channel openers, prevented increased DNA fragmentation
evoked by TNF-
, which were antagonizable by iberiotoxin.
TNF-
-induced increased PTEN phosphorylation and decreased Akt/cyclic
AMP response element-binding protein (CREB) phosphorylation were significantly
prevented by cilostazol, those of which were antagonized by both iberiotoxin
and paxilline, maxi-K channel blockers. The same results were evident in
U87-MG cells transfected with expression vectors for sense PTEN. Cilostazol
increases the K+ current in SK-N-SH cells by activating maxi-K
channels without affecting the ATP-sensitive K+ channel. Thus, our
results for the first time provide evidence that cilostazol prevents
TNF-
-induced cell death by suppression of PTEN phosphorylation and
activation of Akt/CREB phosphorylation via mediation of the maxi-K channel
opening.
This article has been cited by other articles:
![]() |
C.-W. Huang, C.-C. Huang, and S.-N. Wu Activation by Zonisamide, a Newer Antiepileptic Drug, of Large-Conductance Calcium-Activated Potassium Channel in Differentiated Hippocampal Neuron-Derived H19-7 Cells J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 98 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Park, J. H. Lee, C. D. Kim, W. S. Lee, W. S. Park, J. Han, Y.-G. Kwak, K. Y. Kim, and K. W. Hong Cilostazol Suppresses Superoxide Production and Expression of Adhesion Molecules in Human Endothelial Cells via Mediation of cAMP-Dependent Protein Kinase-Mediated Maxi-K Channel Activation J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1238 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, G. T. Oh, S. Y. Park, J.-H. Choi, J.-G. Park, C. D. Kim, W. S. Lee, B. Y. Rhim, Y. W. Shin, and K. W. Hong Cilostazol Reduces Atherosclerosis by Inhibition of Superoxide and Tumor Necrosis Factor-{alpha} Formation in Low-Density Lipoprotein Receptor-Null Mice Fed High Cholesterol J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 502 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Park, J. H. Lee, Y. K. Kim, C. D. Kim, B. Y. Rhim, W. S. Lee, and K. W. Hong Cilostazol Prevents Remnant Lipoprotein Particle-Induced Monocyte Adhesion to Endothelial Cells by Suppression of Adhesion Molecules and Monocyte Chemoattractant Protein-1 Expression via Lectin-Like Receptor for Oxidized Low-Density Lipoprotein Receptor Activation J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1241 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-W. Lin, S.-R. Yang, M.-H. Huang, and S.-N. Wu Stimulatory Actions of Caffeic Acid Phenethyl Ester, a Known Inhibitor of NF-{kappa}B Activation, on Ca2+-activated K+ Current in Pituitary GH3 Cells J. Biol. Chem., June 25, 2004; 279(26): 26885 - 26892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, K. Y. Kim, Y.-K. Lee, S. Y. Park, C. D. Kim, W. S. Lee, B. Y. Rhim, and K. W. Hong Cilostazol Prevents Focal Cerebral Ischemic Injury by Enhancing Casein Kinase 2 Phosphorylation and Suppression of Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation in Rats J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 896 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Wu, S.-I. Liu, and M.-H. Huang Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH3 Cells and Pheochromocytoma PC12 Cells Endocrinology, March 1, 2004; 145(3): 1175 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Kim, H. K. Shin, J. H. Lee, C. D. Kim, W. S. Lee, B. Y. Rhim, Y. W. Shin, and K. W. Hong Cilostazol Enhances Casein Kinase 2 Phosphorylation and Suppresses Tumor Necrosis Factor-{alpha}-Induced Increased Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation and Apoptotic Cell Death in SK-N-SH Cells J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 97 - 104. [Abstract] [Full Text] [PDF] |
||||